EUVIMEDEUVIMED entdecken
Mixed-Methods-StudieOpen Access · CC BY 4.0

Development of a Patient-Centered Pathway of Care for Retinoblastoma Patients: A Mixed-Methods Pilot Study

Ivana Ristevski, Kaitlyn Flegg, Mawj Al-Hammadi, Morgan Livingstone, Taline Dorna, Leslie Low, Jill Robert, Alissa Ulster, Stephanie Kletke, Ashwin Mallipatna, Katherine Paton, Helen Dimaras und 1 weitere

Oncology · 17.07.2024 · 102 (12) · 1056-1071

DOI: 10.1159/000540055 ↗

Kurz gefasst

Mixed-Methods-Studie in der Zeitschrift Oncology, online erschienen am 17.07.2024. Verfasst von Ivana Ristevski und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology & Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada, ivana.ristevski@sickkids.ca. Hauptthemen laut MEDLINE: Retinoblastoma, Patient-Centered Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Retinoblastoma treatment and follow-up is complex and varies between patients. Pathways of care can enhance the quality of care, patient outcomes, safety, satisfaction, and resource optimization. Developing a pathway of care for retinoblastoma was identified as a top research priority by the retinoblastoma community. This study aimed to co-design and pilot a pathway of care called the “Retinoblastoma Journey Map” tailored for caregivers of newly diagnosed children with retinoblastoma.

Methods

A working group of patients, health professionals and researchers used human-centered design to ideate, prototype and refine the Retinoblastoma Journey Map. Caregivers of affected children were recruited to use and evaluate the Map. Mixed-methods data was collected on feasibility, acceptability, usability and perceived impact on communication, self-efficacy, anxiety, depression, and the quality of physician-patient interaction.

Results

The Retinoblastoma Journey Map consisted of an illustrated roadmap with 25 child-friendly stickers covering clinical treatment, medical education and milestones. Quantitative analysis revealed that the Map was feasible, acceptable, and useable; however, no significant effect on communication, self-efficacy, anxiety, depression or quality of physician-patient interaction was observed. Qualitative analysis identified 6 themes: Primary Use; Challenges; Impact; Limitations; Feasibility, Acceptability, and Usability; and Unmet Needs.

Conclusion

A pathway of care for retinoblastoma, co-designed by researchers, health professionals, and patients, was useable, acceptable, and feasible by caregivers of children with retinoblastoma. While significant effects on communication and physician-patient interaction were not observed, “legacy building” – documentation of the pathway of care by families for later education of their child – emerged as an unanticipated yet important use of the Retinoblastoma Journey Map.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RetinoblastomaPatient-Centered CareHumansPilot ProjectsFemaleMaleCaregiversRetinal NeoplasmsPhysician-Patient RelationsAdultChild, PreschoolChildInfantSelf Efficacy

Stichwörter der Autor:innen

Cancer journeyCancer storyPathway of carePatient engagementPatient involvementRetinoblastoma

Autor:innen und Institutionen

  • Department of Ophthalmology & Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada, ivana.ristevski@sickkids.ca.
  • Child Health Evaluative Sciences Program, SickKids Research Institute, Toronto, Ontario, Canada, ivana.ristevski@sickkids.ca.
  • Canadian Retinoblastoma Research Advisory Board, Toronto, Ontario, Canada, ivana.ristevski@sickkids.ca.
  • Department of Ophthalmology & Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Child Health Evaluative Sciences Program, SickKids Research Institute, Toronto, Ontario, Canada.
  • Canadian Retinoblastoma Research Advisory Board, Toronto, Ontario, Canada.

Zitieren

APA

Ristevski, I., Flegg, K., Al-Hammadi, M., Livingstone, M., Dorna, T., Low, L., Robert, J., Ulster, A., Kletke, S., Mallipatna, A., Paton, K., Dimaras, H., & Canadian Retinoblastoma Research Advisory Board (2024). Development of a Patient-Centered Pathway of Care for Retinoblastoma Patients: A Mixed-Methods Pilot Study. Oncology, 102(12), 1056-1071. https://doi.org/10.1159/000540055

Vancouver

Ristevski I, Flegg K, Al-Hammadi M, Livingstone M, Dorna T, Low L, et al. Development of a Patient-Centered Pathway of Care for Retinoblastoma Patients: A Mixed-Methods Pilot Study. Oncology. 2024;102(12):1056-1071. doi:10.1159/000540055

BibTeX
@article{Ristevski2024,
  author = {Ristevski, Ivana and Flegg, Kaitlyn and Al-Hammadi, Mawj and Livingstone, Morgan and Dorna, Taline and Low, Leslie and Robert, Jill and Ulster, Alissa and Kletke, Stephanie and Mallipatna, Ashwin and Paton, Katherine and Dimaras, Helen and Canadian Retinoblastoma Research Advisory Board, Canadian Retinoblastoma Research Advisory Board},
  title = {Development of a Patient-Centered Pathway of Care for Retinoblastoma Patients: A Mixed-Methods Pilot Study},
  journal = {Oncology},
  year = {2024},
  volume = {102},
  number = {12},
  pages = {1056--1071},
  doi = {10.1159/000540055}
}
Kostenlos starten →